Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Open Access
- 1 March 2009
- journal article
- case report
- Published by Elsevier BV in Kidney International
- Vol. 75 (5), 465-474
- https://doi.org/10.1038/ki.2008.496
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: A Sufficient Reason to Avoid Gadolinium-Based Contrast in All Patients with Renal Impairment?Seminars in Dialysis, 2008
- New Insights into Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2007
- Nephrogenic Systemic Fibrosis, Gadolinium, and Iron MobilizationNew England Journal of Medicine, 2007
- Gadolinium and nephrogenic systemic fibrosisKidney International, 2007
- Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?Magnetic Resonance Materials in Physics, Biology and Medicine, 2007
- THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCYNeurosurgery, 2007
- Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis PatientsAmerican Journal of Nephrology, 2005
- Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trialJournal of Magnetic Resonance Imaging, 2004
- Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumoursNeuropathology and Applied Neurobiology, 2004
- Delivery of Virus-sized Iron Oxide Particles to Rodent CNS NeuronsNeurosurgery, 1994